found that CCL18 secreted by TAMs facilitated malignant progression and the glycolytic phenotype in pancreatic cancer, which is partly caused by the paracrine induction of VCAM-1 in pancreatic cancer (83). Here, CCL18 is linked to pancreatic neoplasm.